Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neuroendocrine Carcinoma (Carcinoid)”

147 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 147 results

Testing effectiveness (Phase 2)Study completedNCT01024387
What this trial is testing

AMG 479 in Advanced Carcinoid and Pancreatic Neuroendocrine Tumors

Who this might be right for
Neuroendocrine TumorCarcinoid TumorPancreatic Neuroendocrine Tumor
Dana-Farber Cancer Institute 60
Not applicableLooking for participantsNCT06981455
What this trial is testing

Life Following Excision of Neuroendocrine Tumors

Who this might be right for
Neuroendocrine (NE) TumorsNeuroendocrine Tumor GEP Grade 1-3
Sunnybrook Health Sciences Centre 246
Early research (Phase 1)Ended earlyNCT00002947
What this trial is testing

Indium In 111 Pentetreotide in Treating Patients With Refractory Cancer

Who this might be right for
Brain and Central Nervous System TumorsChildhood Langerhans Cell HistiocytosisGastrointestinal Carcinoid Tumor+9 more
Yale University 35
Testing effectiveness (Phase 2)Study completedNCT02399215
What this trial is testing

Nintedanib in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors

Who this might be right for
Carcinoid TumorMetastatic Carcinoid TumorNeuroendocrine Neoplasm
Roswell Park Cancer Institute 32
Large-scale testing (Phase 3)UnknownNCT01373736
What this trial is testing

123I-MIBG Scintigraphy in Patients Being Evaluated for Neuroendocrine Tumors

Who this might be right for
PheochromocytomaNeuroblastomaParaganglioma+2 more
Vancouver Coastal Health
Large-scale testing (Phase 3)Ended earlyNCT00227136
What this trial is testing

Effect of Oral 5-HTP Intake on Urinary 5-HIAA Excretion

Who this might be right for
Carcinoid TumorsNeuroendocrine Tumors
University of Western Ontario, Canada 8
Testing effectiveness (Phase 2)Study completedNCT01010126
What this trial is testing

Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer

Who this might be right for
Adult Hepatocellular CarcinomaAdvanced Adult Hepatocellular CarcinomaEndometrial Serous Adenocarcinoma+42 more
National Cancer Institute (NCI) 252
Testing effectiveness (Phase 2)Study completedNCT01396382
What this trial is testing

68Ga-DOTATATE PET Scan in Neuroendocrine Cancer

Who this might be right for
Neuroendocrine Carcinoma
Vanderbilt-Ingram Cancer Center 97
Testing effectiveness (Phase 2)Study completedNCT00427349
What this trial is testing

AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine Tumors

Who this might be right for
Gastrointestinal Carcinoid TumorIslet Cell TumorNeoplastic Syndrome
Eastern Cooperative Oncology Group 46
Early research (Phase 1)Ended earlyNCT01165658
What this trial is testing

Study of Hypofractionated Proton Radiation Therapy in Thoracic Malignancies

Who this might be right for
Non-small Cell Lung CancerSmall Cell Lung CancerCarcinoid+2 more
M.D. Anderson Cancer Center 30
Not applicableUnknownNCT00662168
What this trial is testing

An Investigation of Small Intestinal Carcinoid Carcinoma in Families

Who this might be right for
Carcinoid Carcinoma
Rutgers University 8
Testing effectiveness (Phase 2)Study completedNCT00328497
What this trial is testing

A Combination Study to Determine the Safety and Efficacy of Panzem NCD With Avastin in Metastatic Carcinoid Tumors

Who this might be right for
Carcinoid Tumor
CASI Pharmaceuticals, Inc. 31
Testing effectiveness (Phase 2)Study completedNCT02441062
What this trial is testing

Impact of Ga-68 DOTATOC PET-CT Imaging in Management of Neuroendocrine Tumors

Who this might be right for
Neuroendocrine TumorsCarcinoid TumorsNeuroblastoma+1 more
Sue O'Dorisio 122
Testing effectiveness (Phase 2)Study completedNCT00869050
What this trial is testing

Capecitabine and Temozolomide for Neuroendocrine Cancers

Who this might be right for
Neuroendocrine Tumors
Columbia University 41
Testing effectiveness (Phase 2)Study completedNCT00602082
What this trial is testing

Capecitabine and Streptozocin With or Without Cisplatin in Treating Patients With Unresectable or Metastatic Neuroendocrine Tumors

Who this might be right for
Gastrointestinal Carcinoid TumorIslet Cell Tumor
Cambridge University Hospitals NHS Foundation Trust 84
Very early researchActive Not RecruitingNCT04993261
What this trial is testing

An Investigational Scan (Dual Energy CT) in Detecting Gastrointestinal Carcinoid Tumors

Who this might be right for
Carcinoid SyndromeCarcinoid TumorDigestive System Neuroendocrine Tumor G1+1 more
M.D. Anderson Cancer Center 71
Early research (Phase 1)Study completedNCT01263353
What this trial is testing

Safety and Tolerability of Pasireotide LAR in Combination With Everolimus in Advanced Metastatic NETs

Who this might be right for
Gastroenteropancreatic Neuroendocrine Tumor of the Pulmonary ot Gastroenteropancreatic System
Novartis Pharmaceuticals 36
Early research (Phase 1)WithdrawnNCT03057509
What this trial is testing

A Pilot Study Of Ga-68-DOTA-TOC Imaging In Participants With Small Bowel Carcinoid Tumors

Who this might be right for
Small Bowel Carcinoid Tumor
Massachusetts General Hospital
Not applicableNo Longer AvailableNCT01980732
What this trial is testing

68Ga DOTA-TATE PET/CT in Somatostatin Receptor Positive Tumors

Who this might be right for
Carcinoid TumorsIslet Cell (Pancreatic NET)Other Neuroendocrine Tumors
Andrei Iagaru
Early research (Phase 1)Study completedNCT00066404
What this trial is testing

Intrapleural BG00001 in Treating Patients With Malignant Pleural Mesothelioma or Malignant Pleural Effusions

Who this might be right for
Cancer
Abramson Cancer Center at Penn Medicine
Load More Results